| Filed On | Filing |
|---|---|
| 02 Mar 2021 |
Form 3: Wilkins Joseph D Jr., Director
Holds 1 shares of Common Stock |
| 03 Dec 2020 |
Form 3: Hodges Michelle A., SVP, General Counsel
No securities owned |
| 26 Aug 2020 |
Form 3: Ranalli Tamara A., SVP, Molecular Bus. Unit
Holds 8,854 shares of Common Stock |
| 26 Aug 2020 |
Form 3: Rhoads Ann D, Director
No securities owned |
| 27 May 2020 |
Form 3: Ferenczy William J., SVP, Cardio/Metabolic Unit
Holds 4,390 shares of Common Stock |
| 24 Jun 2019 |
Form 3: Ordonez Kathy, Director
No securities owned |
| 13 Feb 2019 |
Form 3: Gibson Karen, SVP, IS & Bus. Transformation
Holds 5,096 shares of Common Stock |
| 18 Dec 2018 |
Form 3: Michael Edward L., Director
No securities owned |
| 06 Apr 2018 |
Form 3: Strobeck Matthew, Director
Holds 3,530 shares of Common Stock |
| 18 Oct 2017 |
Form 3: Borkar Ratan S, SVP, Intl Comm Operations
Holds 15,607 shares of Common Stock |
| 18 Nov 2015 |
Form 3: Slacik Charles P, Director
Holds 0 shares of Common Stock |
| 14 Oct 2015 |
Form 3: Russell Edward Keith, SVP-Global Commercial Ops
Holds 0 shares of Common Stock |
| 21 Jan 2015 |
Form 3: Abney Michael Donald Jr., SVP - Distribution
No securities owned |
| 19 Nov 2014 |
Form 3: Widder Kenneth J, Director
No securities owned |
| 29 May 2014 |
Form 3: Kroll Werner, SVP, R&D
Holds 0 shares of Common Stock |
| 26 Oct 2011 |
Form 3: Steward Randall J, Chief Financial Officer
Holds 0 shares of Common Stock |
| 03 Jun 2011 |
Form 3: Smits Mark W, SVP-Commercial Operations
Holds 0 shares of Common Stock |
| 23 Feb 2010 |
Form 3: Scholl David R., Senior Vice President
Holds 0 shares of No Securities Owned |
| 23 Sep 2009 |
Form 3: Stenzel Timothy Todd, Chief Science Officer
Holds 0 shares of No Holdings |
| 04 Feb 2009 |
Form 3: Bryant Douglas C, Director
Holds 0 shares of Common Stock |
Loading...
